To confirm the in vivo results observed in the NFATc3-deficient mice, we next aimed to determine whether pharmacological inhibition of NFAT by a VIVIT expressing plasmid attenuates sepsis-induced ALI. This evidence concerns the gene NFATC3 and Sepsis.